- Diagnostics
- Friday, 12 Jun 2020
Raxia Launches Contactless COVID-19 Screening and Patient Check-In Solution
Raxia recently surveyed medical practices regarding their COVID-19 screening processes for in-person doctor appointments. The survey, to be published June 22nd, was conducted via email and polled hundreds of doctors, nurses, and medical staff nationwide. While the surveyed practices universally turn away patients thought to have COVID-19, 83% of those same respondents employ protocols that could directly expose their staff and facilities to infected individuals during the screening process.
Raxia Contactless Check-In helps remove the risk of exposing staff and patients to COVID-19 during the check-in and screening process while still providing an excellent patient experience by:
- Asking screening questions via a patient's own mobile device at the time of appointment prior to entering the premises, eliminating physical contact with the intake staff and the facility
- Eliminating waiting rooms with support for queuing workflows
- Directing at-risk patients to the right care facility
- Automating patient intake and appointment reminders for greater efficiency
- Accepting contactless payments and keeping payment details on-file
Raxia Contactless Check-In is not only touch-free and safe but streamlined so more patients can be seen every day, reducing the impact of COVID-19 screening processes on day-to-day healthcare operations.
"You should know whether someone has COVID-19 symptoms before they have any direct interaction with staff or other patients. And you should ask these important questions at the time of appointment to ensure the accuracy, timeliness, and reliability of the information provided," said Andy Kuan, Raxia CEO.
Related Industry Updates
Brain Aneurysm Treatment Market to Witness Rising Demand by 2020-2027 | Stryker Corporation, MicroPort Scientific Corporation, Terumo Corporation, Penumbra, Medtronic and Johnson & Johnson Services, Inc.
Sep 24, 2020
Swiftly Changing Lifestyle is Propelling Atrial Fibrillation in Developing Countries
Mar 17, 2020
Almost 9.6 Million Deaths Across the Globe Were Due to Cancer: Who
Oct 04, 2019
North America Cancer tissue diagnostics market is expected to reach US$ 4,350 million by 2027 with CAGR of 8%.
Oct 20, 2020
Mobile COVID-19 testing set for Leake and Hinds counties
May 20, 2020
Europe Foot Orthotic Insoles Market to Witness an Outstanding Growth During 2020 With Top Key Players Aetrex Worldwide, Inc,Bauerfeind AG,OttoBock,Superfeet Worldwide Inc.,Sidas,Algeos,Yellow Wood Partners, LLC
Dec 02, 2020
OPKO Health's BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies
Apr 30, 2020